US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Yesterday's Top Gainers

736.37

-4.6755-0.63%

Number of Gainers:13

Number of Losers:36

Number of Flat:4

PE:- -

High:740.84

Open:740.84

Low:732.01

Close:741.05

Volume:54.24M

Turnover:781.69M

Market Cap:124.16B

Float Cap:77.22B

Loading ...

Stifel Initiates Immunome at Hold With $24 Price Target

MT Newswires Live

Barclays Remains a Buy on Immunome (IMNM)

RELX plc (RLXXF) Gets a Buy from Barclays

Li Auto September deliveries fall 6.29% to 31,817

Li Auto September Deliveries Rise to 31,817 Vehicles

Li Auto - Delivered 31,817 Vehicles in September 2026

THOMSON REUTERS

Higher Rates Are Reviving Cash Sweep Economics at U.S. Brokerage Stocks

Simply Wall St.

Bridgford Foods Extends Revolving Credit Line Facility

Bridgford Foods Extends Wells Fargo Revolving Credit Line Maturity to Nov. 13, 2026

Kanzhun Limited Files 2026 Interim Report with U.S. SEC

Immunome initiated with a Hold at Stifel

Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (KLRA) and Immunome (IMNM)

Livermore China Concept Stock Leaders Index Edges Higher in Early Trading

Uxin CEO Dai Kun Acquires 8,440 Shares for $10,612.77

Immunome announces IND clearance for IM-1340 in solid tumors

Immunome Says FDA Clears IND for IM-1340 Solid Tumor ADC

Immunome, - to Initiate Phase 1 Study of IM-1340 in Q4 2026

THOMSON REUTERS

Immunome Announces Ind Clearance for IM-1340, a Potential First-in-Class Antibody-Drug Conjugate for the Treatment of Solid Tumors

THOMSON REUTERS

Ocugen to Present 12-Month Phase 2 ArMaDa Trial Results for Ocu410 Gene Therapy in Geographic Atrophy at AAO 2026

Ocugen to Participate in Upcoming Scientific Conferences

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/BK4563/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4563","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4563\",,,,,undefined,":{"symbol":"BK4563","market":"US","secType":"PLATE","nameCN":"Yesterday's Top Gainers","latestPrice":736.37445,"timestamp":1791403199999,"preClose":741.05,"halted":0,"volume":54235810,"delay":0,"changeRate":-0.006309,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-4.675537,"latestTime":"10-07 16:00:00 EDT","open":740.8439,"high":740.8439,"low":732.00745,"amount":781692144.41218,"amplitude":0.011924,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791446400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":1.757702,"peRate":30.786173,"turnoverRate":0.009383,"increases":13,"decrements":36,"flats":2,"marketCap":124161643225,"floatMarketCap":77220324342.75},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4563\",,,,,undefined,":{"symbol":"BK4563","high":740.8439,"amplitude":0.011924,"preClose":741.05,"low":732.00745,"pbRate":"1.757702","latestPrice":736.37445,"volume":54235810,"delay":0,"open":740.8439,"prevYearClose":890.65686,"prevWeekClose":722.8598,"prevMonthClose":737.9837,"prevQuarterClose":737.9837,"fiveDayClose":737.9837,"twentyDayClose":792.4615,"sixtyDayClose":755.4442,"secType":"PLATE","market":"US","turnoverRate":0.009383,"peRate":30.786173,"marketCap":124161643225,"floatMarketCap":77220324342.75,"timestamp":1791403199999,"nameCN":"Yesterday's Top Gainers"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4563\",,,,undefined,":{"bkCode":"BK4563","up":13,"down":36,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4563\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672566347","title":"Stifel Initiates Immunome at Hold With $24 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2672566347","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672566347?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:06","pubTimestamp":1790849175,"startTime":"0","endTime":"0","summary":"Immunome (IMNM) has an average rating of buy and mean price target of $35.20, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4563","IMNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672755365","title":"Barclays Remains a Buy on Immunome (IMNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672755365","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672755365?lang=en_us&edition=fundamental","pubTime":"2026-10-01 17:16","pubTimestamp":1790846160,"startTime":"0","endTime":"0","summary":"In a report released today, Lukas Shumway from Barclays maintained a Buy rating on Immunome, with a price target of $36.00. Shumway covers the Heal...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-buy-on-immunome-imnm-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-buy-on-immunome-imnm-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","BK4139","IMNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672737616","title":"RELX plc (RLXXF) Gets a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2672737616","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672737616?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:36","pubTimestamp":1790836574,"startTime":"0","endTime":"0","summary":"Barclays analyst Nick Dempsey maintained a Buy rating on RELX plc today and set a price target of £31.00. Dempsey covers the Communication Services...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/relx-plc-rlxxf-gets-a-buy-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/relx-plc-rlxxf-gets-a-buy-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLCU","BK4551","BK4075","BK4123","BK4585","RLXXF","XLC","BK4588","BK4563","BK4009","BK4526","WIMI","XLCD","RLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672736274","title":"Li Auto September deliveries fall 6.29% to 31,817","url":"https://stock-news.laohu8.com/highlight/detail?id=2672736274","media":"CnEVPost","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672736274?lang=en_us&edition=fundamental","pubTime":"2026-10-01 10:19","pubTimestamp":1790821199,"startTime":"0","endTime":"0","summary":"Li Auto delivered 99,964 vehicles in the third quarter, up 7.24% year-on-year and 1.66% from the second quarter.","market":"us","thumbnail":"data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20480%20270'%3E%3C/svg%3E","type":0,"news_type":0,"thumbnails":["data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20480%20270'%3E%3C/svg%3E"],"rights":{"source":"cnevpost_highlight","url":"https://cnevpost.com/2026/10/01/li-auto-sept-2026-deliveries/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cnevpost.com/2026/10/01/li-auto-sept-2026-deliveries/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"cnevpost_highlight","symbols":["BK4503","BK4585","BK4563","BK4588","BK4548","BK4526","LI","BK4555","02015","EVS.SI","BK4099","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672773666","title":"Li Auto September Deliveries Rise to 31,817 Vehicles","url":"https://stock-news.laohu8.com/highlight/detail?id=2672773666","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672773666?lang=en_us&edition=fundamental","pubTime":"2026-10-01 10:03","pubTimestamp":1790820202,"startTime":"0","endTime":"0","summary":"Li Auto September deliveries rise to 31,817 vehiclesLi Auto delivered 31,817 vehicles in September 2026; cumulative deliveries reached 1,833,651 as of Sept. 30.More than 10,000 units of the new Li L6 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL7ZCHP9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02015","BK4526","LI","BK4585","BK4588","BK4555","BK4503","EVS.SI","BK4548","BK4099","BK4563","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672736653","title":"Li Auto - Delivered 31,817 Vehicles in September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672736653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672736653?lang=en_us&edition=fundamental","pubTime":"2026-10-01 10:03","pubTimestamp":1790820187,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45M1AR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4526","02015","BK4548","LI","BK4555","BK4563","BK4585","BK4588","BK4503","BK4551","BK4099","EVS.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672384107","title":"Higher Rates Are Reviving Cash Sweep Economics at U.S. Brokerage Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2672384107","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672384107?lang=en_us&edition=fundamental","pubTime":"2026-10-01 06:22","pubTimestamp":1790806976,"startTime":"0","endTime":"0","summary":"Higher for longer interest rates are turning idle cash into a real line item again, and that puts money-center brokerages and custodians squarely in focus. When the Fed keeps policy tight and short-term yields stay attractive, the gap between what client cash earns and what a platform collects can matter a lot more to your portfolio. This article unpacks that story and profiles 3 U.S. brokerage stocks most directly exposed to this rate backdrop.\nThe three brokerages highlighted below are just...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/7131000-choice1-card/1788935066370","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/7131000-choice1-card/1788935066370"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/diversified-financials/nasdaq-alti/alti-global/news/higher-rates-are-reviving-cash-sweep-economics-at-us-brokera","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/diversified-financials/nasdaq-alti/alti-global/news/higher-rates-are-reviving-cash-sweep-economics-at-us-brokera","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4587","BK4563","NQGM","LU1981816686.USD","BK4127","FUTG","LU2279858448.HKD","SG9999002463.SGD","LU0072462343.USD","LU0348766576.USD","BK4585","BK4526","FUTU","TIGR","LU0348767384.USD","ALTI","LU1048588211.SGD","BK4566","BK4509","BK4503","LU1171460220.USD","BK4588","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672578051","title":"Bridgford Foods Extends Revolving Credit Line Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2672578051","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672578051?lang=en_us&edition=fundamental","pubTime":"2026-10-01 05:17","pubTimestamp":1790803073,"startTime":"0","endTime":"0","summary":"An announcement from Bridgford Foods ( ($BRID) ) is now available. On September 30, 2026, Bridgford Foods Corporation entered into a 45-day extensi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bridgford-foods-extends-revolving-credit-line-facility?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bridgford-foods-extends-revolving-credit-line-facility?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BRID","BK4212","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672876267","title":"Bridgford Foods Extends Wells Fargo Revolving Credit Line Maturity to Nov. 13, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672876267","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672876267?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:56","pubTimestamp":1790801770,"startTime":"0","endTime":"0","summary":"Bridgford Foods extends Wells Fargo revolving credit line maturity to Nov. 13, 2026Bridgford Foods signed a 45-day extension of its revolving line of credit with Wells Fargo, moving maturity to Nov. 1","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL3Y5GSF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4212","BRID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672787806","title":"Kanzhun Limited Files 2026 Interim Report with U.S. SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=2672787806","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672787806?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:29","pubTimestamp":1790800144,"startTime":"0","endTime":"0","summary":"Kanzhun Ltd Sponsored ( ($BZ) ) has provided an update. Kanzhun Limited has filed a Form 6-K with the U.S. Securities and Exchange Commission for t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kanzhun-limited-files-2026-interim-report-with-u-s-sec?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kanzhun-limited-files-2026-interim-report-with-u-s-sec?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU2187417386.USD","BK4077","BK4503","BZ","BK4585","BK4505","BK4509","LU2351347302.SGD","LU1023057109.AUD","LU2929501877.USD","LU0359201612.USD","BK4539","IE00B29SXG58.USD","LU2039709279.SGD","LU1688375341.USD","BK4563","BK4535","BK4130","BK4526","LU0359202008.SGD","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672829777","title":"Immunome initiated with a Hold at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2672829777","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672829777?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:10","pubTimestamp":1790799015,"startTime":"0","endTime":"0","summary":"Stifel analyst Dara Azar initiated coverage of Immunome (IMNM) with a Hold rating and $24 price target Varegacestat’s “debatable differentiation” o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunome-initiated-with-a-hold-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunome-initiated-with-a-hold-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","IMNM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671851997","title":"Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (KLRA) and Immunome (IMNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671851997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671851997?lang=en_us&edition=fundamental","pubTime":"2026-09-30 23:20","pubTimestamp":1790781616,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Kailera Therapeutics, Inc. (KLRA) and Immunome (IMNM...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kailera-therapeutics-inc-klra-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kailera-therapeutics-inc-klra-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4563","BK4137","HCSG","BK4585","LU0128526141.USD","OZEM","BK4139","IMNM","LABU","XBI","XLV","KLRA","LU0029874061.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175759280","title":"Livermore China Concept Stock Leaders Index Edges Higher in Early Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1175759280","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175759280?lang=en_us&edition=fundamental","pubTime":"2026-09-30 22:31","pubTimestamp":1790778717,"startTime":"0","endTime":"0","summary":"On September 30, the Livermore China Concept Stock Leaders Index rose 0.6% in early trading to reach 9,229.35 points.Among its constituent stocks, ChipMOS Technologies climbed 5.87%, KE Holdings Inc....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDS","LU1831875114.USD","BK1587","LU1515016050.SGD","BK4509","LU0359201612.USD","BK4529","02423","LU0244354667.USD","LU1688375341.USD","BK4503","BK4099","BK4116","LU0326950275.SGD","BK4607","LI","BK4505","BK4563","BEKE","LU1023057109.AUD","LU1188198961.HKD","LU1051768304.USD","02015","BK1588","LU0651946864.USD","BK4614","BK4504","09698","BK4079","LU0651947912.USD","BK4585","LU1051769294.HKD","BK4551","BK4531","HCM","BK1191","BK4555","LU0359201885.HKD","BK4548","BK4588","BK4526","00013","LU0287142896.SGD","LU0359202008.SGD","LU0463099449.HKD","EVS.SI","LU0173614495.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671207245","title":"Uxin CEO Dai Kun Acquires 8,440 Shares for $10,612.77","url":"https://stock-news.laohu8.com/highlight/detail?id=2671207245","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671207245?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:32","pubTimestamp":1790775137,"startTime":"0","endTime":"0","summary":"Uxin CEO Dai Kun acquires 8,440 shares for $10,612.77Uxin CEO Dai Kun reported an indirect purchase of 8,440 American depositary shares at USD 1.2572 each.Holding stood at 8,440 ADS following the trad","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL4P9DHF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Uxin CEO Dai Kun Acquires 8,440 Shares for $10,612.77","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","UXIN","BK4122","BK4214","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671201677","title":"Immunome announces IND clearance for IM-1340 in solid tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2671201677","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671201677?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:50","pubTimestamp":1790769014,"startTime":"0","endTime":"0","summary":"Immunome (IMNM) announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for IM-1340, a potential ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunome-announces-ind-clearance-for-im-1340-in-solid-tumors-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunome-announces-ind-clearance-for-im-1340-in-solid-tumors-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMNM","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671094462","title":"Immunome Says FDA Clears IND for IM-1340 Solid Tumor ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2671094462","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671094462?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:45","pubTimestamp":1790768728,"startTime":"0","endTime":"0","summary":"Immunome says FDA clears IND for IM-1340 solid tumor ADCFDA cleared Immunome’s IND for IM-1340, a first-in-class antibody-drug conjugate for advanced solid tumors.Phase 1 trial is slated to start in Q","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDLcfX96:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","IMNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671209447","title":"Immunome, - to Initiate Phase 1 Study of IM-1340 in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671209447","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671209447?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:45","pubTimestamp":1790768700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUA67F0BB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMNM","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671209423","title":"Immunome Announces Ind Clearance for IM-1340, a Potential First-in-Class Antibody-Drug Conjugate for the Treatment of Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2671209423","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671209423?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:45","pubTimestamp":1790768700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUA67F0BB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","IMNM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671619206","title":"Ocugen to Present 12-Month Phase 2 ArMaDa Trial Results for Ocu410 Gene Therapy in Geographic Atrophy at AAO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671619206","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671619206?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:05","pubTimestamp":1790766359,"startTime":"0","endTime":"0","summary":"Ocugen to present 12-month Phase 2 ArMaDa trial results for OCU410 gene therapy in geographic atrophy at AAO 2026Ocugen flagged upcoming presentations of clinical trial results for its modifier gene t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL9lldjv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4139","IE00BN0W2W23.USD","SG9999014013.SGD","OCGN","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","NDAQ","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BCDF","BK4568","IE00BQXX3C00.GBP","LU2210150020.SGD","BK4588","LU2210149790.SGD","BK4563","LU0314104364.USD","BK4112","IE00B64PRP62.GBP","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4585","SG9999014005.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671620147","title":"Ocugen to Participate in Upcoming Scientific Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2671620147","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671620147?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:02","pubTimestamp":1790766120,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Sept.  30, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology company developing gene therapies for blindness diseases, today announ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/30/3371762/0/en/ocugen-to-participate-in-upcoming-scientific-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","EIS","BK4139","OCGN","BK4563"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}